White Paper

A platform striving for content leadership

April 6, 2016

In the fight against pathogen resistance, Curetis is constantly adapting its products to meet evolving clinical needs. Its Unyvero platform, designed as a solution to the global spread of antibiotic resistances, is seeing ongoing improvements and adaptations to suit the needs of its users. CEO Oliver Schacht tells us about the Unyvero platform and its future in the field of diagnostics.

Download to find out more.